Uveal Melanoma, Chromosome 3 Monosomy, FISH, Tissue
Uveal melanoma is the most common primary intraocular malignancy in adults and carries a high risk of metastasis, with nearly 50% of patients developing metastatic disease within 15 years. The uveal tract includes the iris, ciliary body, and choroid, with most tumors arising in the choroid. A key prognostic biomarker in uveal melanoma is monosomy of chromosome 3 (loss of one copy of chromosome 3).
Tumors with monosomy 3 are associated with a poor prognosis and high metastatic potential, especially to the liver. Chromosome 3 harbors several critical genes, including BAP1 (BRCA1-associated protein 1), a tumor suppressor gene. Loss of one allele results in reduced tumor suppressor activity, contributing to tumor progression and aggressive behavior. Fluorescence in situ hybridization (FISH) assay targeting chromosome 3 loci provides a reliable method for detecting monosomy, making it useful for both diagnosis and prognostication of uveal melanoma.
- Confirms diagnosis in suspected uveal melanoma
- Provides prognostic information, identifying patients at higher risk of metastasis
Positive: Detection of monosomy 3 indicates poor prognosis and increased metastatic risk in uveal melanoma.
Negative: No evidence of monosomy 3. Does not exclude the diagnosis of uveal melanoma; other molecular alterations may be involved.
Negative
Fluorescent in-situ hybridization (FISH).
Tissue, Formalin-fixed paraffin-embedded (FFTP) tumor tissue block.
Fixed tissues are stable at room temperature for long time.
- Ophthalmology. 2007 Oct;114(10):1925-31. [PMID: 17719643]
- Curr Opin Ophthalmol. 2022 May 1;33(3):202-210. [PMID: 35102096]
- Br J Cancer. 2012 Mar 13;106(6):1171-6. [PMID: 22353812]
- Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1008-11. [PMID: 12601021]